Sector portfolio · Private equity · United States

ArrowMark Partners' Biotech portfolio

ArrowMark Partners has backed 13 Biotech startups in rounds we track, $2.8B between them, shown by the stage each has reached. The best-funded is Moderna.

13startups backed
3stages
$2.8Braised between them
Series C and laterbiggest stage

ArrowMark Partners's profile

Series C and later

6

Series B

5

Stage not reported

2

Segment by segment

Series C and later

6 startups · $1.6B raised

  1. ModernaLearn how we’re changing the world of medicine.United States$675M
  2. Orchard TherapeuticsOrchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.United Kingdom$377M
  3. MetacrineMetacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs.United States$173M
  4. AAscentageUnited States$150M
  5. ArcherDXArcherDX is a biotechnology firm specializing in cancer research.United States$150M
  6. CCentrexionUnited States$90M

Series B

5 startups · $737M raised

  1. SpringWorks TherapeuticsSpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.United States$400M
  2. Neon TherapeuticsNEON Therapeutics is focused on unlocking the full potential of the immune system to recognize and attack cancer.United States$161M
  3. TTCR2United States$125M
  4. Lyra TherapeuticsLyra Therapeutics is a clinical-stage company developing medicines to treat ear, nose, and throat diseases.United States$30M
  5. NextCureNextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.United States$22M

Stage not reported

2 startups · $408M raised

  1. Dren BioDren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.United States$375M
  2. KodiakKodiak, a division of Motorola Solutions based in Plano, Texas, specializes in broadband push-to-talk (PTT) communication platformUnited States$33M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names ArrowMark Partners as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Co-investorsWho invests with ArrowMark Partners21 co-investorsSector portfolioRA Capital Management's Biotech portfolio197 startups · $38BSector portfolioOrbiMed's Biotech portfolio176 startups · $28BSector portfolioPioneer Fund's AI portfolio171 startups · $2.8BSector portfolioGaingels' AI portfolio146 startups · $14BSector portfolioCormorant Asset Management's Biotech portfolio95 startups · $21B

Raising from investors like ArrowMark Partners?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps